<DOC>
	<DOCNO>NCT00137501</DOCNO>
	<brief_summary>Preterm birth one important cause perinatal morbidity mortality worldwide . Prevention treatment preterm labor important , end , mean reduce adverse event neonate . A wide range tocolytics , drug use suppress uterine contraction , try . Magnesium sulfate ( MgSO4 ) widely use tocolytic American University Beirut Medical Center despite fact effective tocolytic role MgSO4 never establish . Moreover , currently available data suggestive deleterious fetal effect MgSO4 set preterm labor extent authority recommend abandon routine use tocolytic therapy . Calcium channel blocker ability inhibit contractility smooth muscle cell . Consequently , nifedipine emerge effective rather safe alternative tocolytic agent management preterm labor several study show use nifedipine comparison tocolytics associate frequent successful prolongation pregnancy , result significantly few admission newborn neonatal intensive care unit , associate low incidence respiratory distress syndrome . The unequivocal impact method tocolysis short term postponement delivery opportunity provide affect in-utero transfer steroid administration prompt many investigator recommend focus future trial test different dose regimen nifedipine . To best investigator ' knowledge , study compare two different dose regimen nifedipine previously publish literature . The objective study compare effectiveness high versus low dose regimen total 200 patient admitted diagnosis preterm labor 24 34 week gestation . In addition , investigator ' study try ass safety profile 2 dose regimen mother neonate assessing select number outcome variable . The data generate used change protocol manage patient present threatened preterm delivery fill exist gap regard effective safest dose regimen nifedipine patient .</brief_summary>
	<brief_title>Two Dose Regimens Nifedipine Management Preterm Labor</brief_title>
	<detailed_description>RESEARCH DESIGN AND METHODS Inclusion criterion : - All pregnant woman diagnose preterm labor define regular contraction associate cervical change 24 34 week gestation . Exclusion criterion : - Multiple pregnancy - Preterm rupture membrane - Congenital fetal malformation - IUGR ( intra uterine growth restriction ) - Previous tocolysis pregnancy - Chorioamnionitis - Cervical dilation &gt; 4 cm - Maternal medical condition renal insufficiency , hepatic insufficiency , myasthenia gravis - Non-reassuring fetal heart rate - Maternal hypotension , define blood pressure &lt; 90/50 mm Hg Randomization procedure : Randomization envelope prepare mean random number table . After informed consent obtain , next numbered opaque envelope open assign patient receive either low high nifedipine dose regimen . Because different dos nifedipine , neither patient physician blind treatment allocation . Routine study procedure : - A baseline ECG perform start medication . - All patient receive 500-mL intravenous bolus isotonic sodium chloride solution unless clinical volume overload , follow maintenance administration 125 mL/h . - Maternal blood pressure heart rate record every 15 minute long patient labor every 4 hour thereafter . - Fetal heart rate uterine activity monitor continuously throughout study period . - All patient eligible study receive antibiotic prophylaxis Group B Streptococcal infection ( IV Pen G Ampicillin ) least 48 hour , pending vaginorectal swab culture do routinely every patient present preterm labor . - All patient receive one course 12 mg betamethasone intramuscularly every 24 hour 48 hour promote fetal lung maturation rescue dose present labor &lt; 34 week gestation . Interventions : First arm ( high dose ) : Nifedipine ( Adalat® ) 20 mg sublingual crush , repeat 30 minute contraction decrease intensity . Maintenance 120-160 mg slow-release nifedipine ( Nifedicor® ) daily 48 hour ( 30 mg Q 6 hr maximum 40 mg Q 6 hr ) . Once contraction cease , nifedipine maintain 80-120 mg daily divide dose 36 week gestation outside basis . Second arm ( low dose ) : Nifedipine ( Adalat® ) 10 mg sublingual crush , 10 mg sublingual 15 min , follow 10 mg PO Q 15 min PRN maximum 40 mg first hour . Maintenance 60-80 mg slow-release nifedipine ( Nifedicor® ) daily 48 hour ( 20 mg Q 8 hr 20 mg Q 6 hr ) . Once contraction cease , nifedipine maintain 60 mg daily divide dose 36 week gestation . - Tocolysis consider achieved uterine activity decrease &lt; 4 contractions/h absence cervical change . - If patient continue uterine activity 6 hour cervical dilatation &gt; 2 cm admission examination , could switch another tocolytic regimen , namely intravenous MgSO4 intravenous ritodrine . Written Consent : The write consent hand every pregnant patient eligible study . She give enough time read decide whether willing participate trial . Outcome variable study : - Speed onset uterine quiescence - Uterine quiescence 6 hour initiate therapy - Delivery &gt; 48 hour initiation therapy - Delivery &gt; 7 day initiation therapy - Delivery &lt; 37 week gestation - Delivery &lt; 34 week gestation - Side effect nifedipine - Maternal adverse drug reaction require cessation treatment - Antepartum hemorrhage - Maternal length hospital stay - Pregnancy prolongation - Postpartum hemorrhage - Birthweight - Apgar score &lt; 7 5 min - Admission NICU - Mechanical ventilation - RDS ( respiratory distress syndrome ) - IVH grade - Neonatal nursery stay - Neonatal jaundice - NEC ( Necrotizing enterocolitis ) - Neonatal death Side effect associate nifedipine include mild decrease blood pressure rise pulse , headache , flushing , dizziness nausea . Data Collection : The initial information data sheet fill resident charge delivery suite . However , follow response patient medication data regard maternal side effect neonatal outcome fill part time research assistant . Statistical Analysis : Statistical analysis perform use SPSS statistical package . Categoric data like maternal characteristic , rate neonatal morbidity mortality compare use Chi square sample size support approximation . Otherwise , categorical data analyze two-tailed Fisher exact test expect cell frequency small . Continuous variable compare Student test assumption normality homogeneity variance appear reasonable . Unpaired variable difference distribution compare use Mann-Whitney test . Neonatal outcomes analyze compare total number affect neonate group . A p-value &lt; 0.05 consider statistically significant . Proposed budget : Personnel : A part time research assistant `` BS '' background 450,000 L.L./ month x 29 month =13,050,000 L.L . Tasks expect : Completing data sheet : - F/U response mother tocolysis assess maternal side effect - F/U neonates get information neonatal outcome variable - Data entry Medical supply : Medications provide pharmacy . Compensation patient : The total amount money need Lebanese pound : 13,050,000 L.L./year . Time frame : - May 2003 - May 2006 - Collection data randomization patient 2 arm study - June 2006 - Sep 2006 - Follow patient randomize first 5 month 2006 get information pregnancy outcome - Oct 2006 - Nov 2006 - Data analysis write final paper Data collection direct supervision principal investigator . Percent time spend principal investigator proposal : 20 % research time account 20 % time allocate research activity . Co-Investigators ' Role : - Dr Usta help data analysis write final paper ( 5 % research time ) - Dr Mroueh help write final paper ( 5 % research time ) . Two Investigational Drug form use since trial involve drug nifedipine 2 different form Adalat® Nifedicor® . Principal Investigator : Anwar Nassar , MD , Assistant Professor , American University Beirut Medical Center , Department Obstetrics Gynecology Co-Investigators : Ihab Usta , MD , Associate Professor , American University Beirut Medical Center , Department Obstetrics Gynecology Adnan Mroueh , MD , Professor , American University Beirut Medical Center , Department Obstetrics Gynecology REFERENCES : Assessment Risk Factors Preterm Birth . ACOG practice bulletin , Number 31 , October 2001 . Mittendorf R , Dambrosia J , Pryde PG , Lee KS , Gianopoulos JG , Besinger RE , Tomich PG . Association use antenatal magnesium sulfate preterm labor adverse health outcome infant . Am J Obstet Gynecol ; 186 ( 6 ) :1111-8 . June 2002 . Gyetvai K , Hannah ME , Hodnett ED , Ohlsson A. Tocolytics preterm labor : systematic review . Obstet Gynecol ; 94 ( 5 Pt 2 ) :869-77 . Nov 1999 . Mittendorf R , Covert R , Elin R , Pryde PG , Khoshnood B , Lee KS . Umbilical cord serum ionized magnesium level total pediatric mortality . Obstet Gynecol ; 98 ( 1 ) :75-8 . July 2001 . Weerakul W , Chittacharoen A , Suthutvoravut S. Nifedipine versus terbutaline management preterm labor . Int J Gynaecol Obstet ; 76 ( 3 ) :311-3 . Mar 2002 . Papatsonis DN , Van Geijn HP , Ader HJ , Lange FM , Bleker OP , Dekker GA. Nifedipine ritodrine management preterm labor : randomized multicenter trial . Obstet Gynecol ; 90 ( 2 ) :230-4 . Aug 1997 . Larmon JE , Ross BS , May WL , Dickerson GA , Fischer RG , Morrison JC . Oral nicardipine versus intravenous magnesium sulfate treatment preterm labor . Am J Obstet Gynecol ; 181 ( 6 ) :1432-7 . Dec1999 . Koks CA , Brolmann HA , de Kleine MJ , Manger PA. A randomize comparison nifedipine ritodrine suppression preterm labor . Eur J Obstet Gynecol Reprod Biol ; 77 ( 2 ) :171-6 . Apr 1998 .</detailed_description>
	<mesh_term>Obstetric Labor , Premature</mesh_term>
	<mesh_term>Nifedipine</mesh_term>
	<criteria>All pregnant woman diagnose preterm labor define regular contraction associate cervical change 24 34 week gestation Multiple pregnancy Preterm rupture membrane Congenital fetal malformation IUGR ( intra uterine growth restriction ) Previous tocolysis pregnancy Chorioamnionitis Cervical dilation &gt; 4 cms Maternal medical condition renal insufficiency , hepatic insufficiency , myasthenia gravis Nonreassuring fetal heart rate Maternal hypotension , define blood pressure &lt; 90/50 mmHg</criteria>
	<gender>Female</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>